ACB Stock Overview
Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Aurora Cannabis Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$8.00 |
| 52 Week High | CA$13.10 |
| 52 Week Low | CA$3.84 |
| Beta | 2.72 |
| 11 Month Change | -16.23% |
| 3 Month Change | 2.70% |
| 1 Year Change | -30.43% |
| 33 Year Change | -89.78% |
| 5 Year Change | -99.01% |
| Change since IPO | -85.19% |
Recent News & Updates
It's Unlikely That Aurora Cannabis Inc.'s (TSE:ACB) CEO Will See A Huge Pay Rise This Year
Aug 02
Aurora Cannabis Inc.'s (TSE:ACB) Share Price Is Still Matching Investor Opinion Despite 29% Slump
Jun 27Recent updates
It's Unlikely That Aurora Cannabis Inc.'s (TSE:ACB) CEO Will See A Huge Pay Rise This Year
Aug 02Aurora Cannabis Inc.'s (TSE:ACB) Share Price Is Still Matching Investor Opinion Despite 29% Slump
Jun 27Why Aurora Cannabis' (TSE:ACB) Earnings Are Weaker Than They Seem
Feb 15Is Aurora Cannabis (TSE:ACB) Using Too Much Debt?
Sep 12Investors Holding Back On Aurora Cannabis Inc. (TSE:ACB)
Jun 13Is Aurora Cannabis (TSE:ACB) Using Debt Sensibly?
Jan 15Downgrade: Here's How Analysts See Aurora Cannabis Inc. (TSE:ACB) Performing In The Near Term
Nov 13Does Aurora Cannabis (TSE:ACB) Have A Healthy Balance Sheet?
Sep 22Aurora Cannabis (TSE:ACB) Is Carrying A Fair Bit Of Debt
Apr 21Is Aurora Cannabis (TSE:ACB) Using Too Much Debt?
Jan 05Shareholder Returns
| ACB | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 1.9% | -1.1% | 2.8% |
| 1Y | -30.4% | -18.1% | 14.1% |
Return vs Industry: ACB underperformed the Canadian Pharmaceuticals industry which returned -18.1% over the past year.
Return vs Market: ACB underperformed the Canadian Market which returned 14.1% over the past year.
Price Volatility
| ACB volatility | |
|---|---|
| ACB Average Weekly Movement | 9.3% |
| Pharmaceuticals Industry Average Movement | 10.4% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in CA Market | 16.9% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: ACB has not had significant price volatility in the past 3 months.
Volatility Over Time: ACB's weekly volatility has decreased from 15% to 9% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 1,073 | Miguel Martin | www.auroramj.com |
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.
Aurora Cannabis Inc. Fundamentals Summary
| ACB fundamental statistics | |
|---|---|
| Market cap | CA$430.18m |
| Earnings (TTM) | -CA$30.32m |
| Revenue (TTM) | CA$278.98m |
1.6x
P/S Ratio-14.4x
P/E RatioIs ACB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ACB income statement (TTM) | |
|---|---|
| Revenue | CA$278.98m |
| Cost of Revenue | CA$129.00m |
| Gross Profit | CA$149.99m |
| Other Expenses | CA$180.31m |
| Earnings | -CA$30.32m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.55 |
| Gross Margin | 53.76% |
| Net Profit Margin | -10.87% |
| Debt/Equity Ratio | 8.7% |
How did ACB perform over the long term?
See historical performance and comparison